Discontinued — last reported Q3 '23
An increase suggests potential overvaluation of assets or a deterioration in the long-term outlook for specific animal health products or manufacturing capabilities, while a decrease indicates stable asset valuation.
This metric represents non-cash charges recognized when the carrying value of long-lived assets within the animal health...
Peers in the animal health and broader pharmaceutical space report similar impairment charges under GAAP or IFRS when testing for asset recoverability.
lly_segment_animal_health_asset_impairment_charges